![Paolo Fundarò](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paolo Fundarò
Fondateur chez
Xgen Venture Sgr SpA
Profil
Before co-founding XGEN in2021, Paolo was in Genextra since its inception, serving as CEO up to 2022.
Paolo is also board member and co-investor of a number of Genextra companies including Targimmune Therapeutics and Erydel; he is board member and Chairman of Intercept Pharmaceutical (NADAQ: ICPT) since 2006.
Prior to Genextra, he acquired several start-up experiences, including e.Biscom/Fastweb (2000-2004), and investment banking in London.
Paolo is co-founder of Italian Angels for Biotech (IAB).
He holds a cum laude degree in B.A. & Finance from Bocconi University.
Postes actifs de Paolo Fundarò
| Sociétés | Poste | Début |
|---|---|---|
EryDel SpA
 EryDel SpA BiotechnologyHealth Technology Operates as a biotech company that develops therapeutics for the treatment of rare diseases | Directeur/Membre du Conseil | 01/01/2013 |
Applango Systems Ltd.
 Applango Systems Ltd. Packaged SoftwareTechnology Services Provides software tools for enterprise organizations | Directeur/Membre du Conseil | 01/01/2012 |
Applango USA, Inc.
 Applango USA, Inc. Packaged SoftwareTechnology Services Develops salesforce application | Directeur/Membre du Conseil | 01/01/2013 |
InnovHeart Srl
 InnovHeart Srl Medical SpecialtiesHealth Technology Manufactures and commercializes medical devices | Directeur/Membre du Conseil | 01/12/2015 |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Directeur/Membre du Conseil | 01/06/2020 |
Xgen Venture Sgr SpA
 Xgen Venture Sgr SpA Investment ManagersFinance XGEN Venture invests in companies located in Italy. The firm focuses on the life science sectors. It participates in early stage capital transactions. | Fondateur | 01/06/2021 |
Anciens postes connus de Paolo Fundarò
| Sociétés | Poste | Fin |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Président | 08/11/2023 |
Genextra SpA
 Genextra SpA Investment ManagersFinance Genextra invest in companies located Italy. The firm focuses on the life science companies. It participates in early stage capital transactions. | Directeur Général | 01/07/2022 |
| TESSELLIS S.P.A. | Directeur/Membre du Conseil | 17/05/2022 |
| ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Paolo Fundarò
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Credit Suisse (USA) LLC
 Credit Suisse (USA) LLC Investment Banks/BrokersFinance Provides investment banking and asset management services | Finance |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Congenia Srl
 Congenia Srl Miscellaneous Commercial ServicesCommercial Services Develops and produces molecular drugs and pharmaceutical products | Commercial Services |
Tessellis SpA
 Tessellis SpA Major TelecommunicationsCommunications Operates as a holding company whose subsidiaries provides internet access, telephony and multimedia services | Communications |
Fastweb SpA
 Fastweb SpA Major TelecommunicationsCommunications Provides fiber broadband carrier services | Communications |
University of Bocconi
 University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Salomon Smith Barney International Ltd.
 Salomon Smith Barney International Ltd. Investment Banks/BrokersFinance Security Broker | Finance |
Genextra SpA
Genextra SpA Investment ManagersFinance Genextra invest in companies located Italy. The firm focuses on the life science companies. It participates in early stage capital transactions. | Finance |
EryDel SpA
EryDel SpA BiotechnologyHealth Technology Operates as a biotech company that develops therapeutics for the treatment of rare diseases | Health Technology |
Tethis SpA
 Tethis SpA BiotechnologyHealth Technology Develops liquid biopsy platforms and AI-assisted diagnostic solutions for cancer detection and precision medicine | Health Technology |
Applango USA, Inc.
Applango USA, Inc. Packaged SoftwareTechnology Services Develops salesforce application | Technology Services |
Applango Systems Ltd.
Applango Systems Ltd. Packaged SoftwareTechnology Services Provides software tools for enterprise organizations | Technology Services |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Health Technology |
Dac SRL
 Dac SRL Motor VehiclesConsumer Durables Manufactures and sells car, bike, motorbike accessories and spare parts | Consumer Durables |
InnovHeart Srl
InnovHeart Srl Medical SpecialtiesHealth Technology Manufactures and commercializes medical devices | Health Technology |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance XGEN Venture invests in companies located in Italy. The firm focuses on the life science sectors. It participates in early stage capital transactions. | Finance |
